One way of achieving this is altering the presented protein fragment’s size and therefore affinity to bind to the MHC-class I-complex or recognizability to the TCR, which has been identified as a pivotal mechanism in viral infections [40,41]. This evidence concerns the gene HLA-C and viral infectious disease.